scholarly article | Q13442814 |
P50 | author | Marilia Brito Gomes | Q88048537 |
P2093 | author name string | Gomes MB | |
Mattar R | |||
Guedes MF | |||
Montenegro Junior RM | |||
Negrato CA | |||
Von Kostrisch LM | |||
P2860 | cites work | Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog). | Q30879494 |
Survey of glargine use in 115 pregnant women with Type 1 diabetes | Q33316172 | ||
Insulin glargine safety in pregnancy: a transplacental transfer study | Q33556840 | ||
Insulin aspart: a new rapid-acting insulin analog | Q34122518 | ||
Effect of treatment of gestational diabetes mellitus on pregnancy outcomes | Q34558501 | ||
Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study | Q34805336 | ||
Intermediate metabolism in normal pregnancy and in gestational diabetes. | Q35184288 | ||
Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes | Q35198990 | ||
Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool? | Q36092959 | ||
Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study | Q36245629 | ||
Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994. | Q36245644 | ||
Treatment with insulin and its analogs in pregnancies complicated by diabetes | Q36862933 | ||
Perinatal outcomes associated with the use of glargine during pregnancy | Q37035503 | ||
Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group | Q37075365 | ||
Insulin treatment in diabetic pregnancy | Q37144833 | ||
Insulin glargine versus neutral protamine Hagedorn insulin for treatment of diabetes in pregnancy | Q37315640 | ||
Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands | Q37513861 | ||
Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis | Q37826022 | ||
Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes | Q37873889 | ||
Randomized trial of human versus animal species insulin in diabetic pregnant women: improved glycemic control, not fewer antibodies to insulin, influences birth weight | Q41101517 | ||
Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomia | Q41204557 | ||
Metabolic and immunologic effects of insulin lispro in gestational diabetes | Q41689564 | ||
Risk factors and obstetric complications associated with macrosomia | Q43540877 | ||
Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. | Q43903152 | ||
Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus | Q44126489 | ||
Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus | Q44262770 | ||
Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro | Q44381386 | ||
Transfer of insulin lispro across the human placenta: in vitro perfusion studies | Q44418797 | ||
Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women | Q44616167 | ||
A randomised controlled trial of insulin lispro given before or after meals in pregnant women with type 1 diabetes--the effect on glycaemic excursion | Q44941526 | ||
Threshold values of maternal blood glucose in early diabetic pregnancy--prediction of fetal malformations. | Q45189752 | ||
Maternal mortality in type 1 diabetes | Q46352960 | ||
Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study | Q46357269 | ||
Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. | Q46618833 | ||
Fetal and neonatal outcomes of diabetic pregnancies | Q47578817 | ||
Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. | Q53199148 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | preproinsulin | Q7240673 |
gestational diabetes | Q126691 | ||
P304 | page(s) | 405-14 | |
P577 | publication date | 2012-10-01 | |
P1433 | published in | Arquivos Brasileiros de Endocrinologia e Metabologia | Q15751181 |
P1476 | title | Insulin analogues in the treatment of diabetes in pregnancy | |
P478 | volume | 56 |
Q30238619 | Different insulin types and regimens for pregnant women with pre-existing diabetes. |
Q24186739 | Insulin for the treatment of women with gestational diabetes |
Q46301748 | Insulin for the treatment of women with gestational diabetes. |
Q33719410 | Is a low level of free thyroxine in the maternal circulation associated with altered endothelial function in gestational diabetes? |
Q37031287 | PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns |
Q93167299 | Successful Outcomes with Insulin Degludec in Pregnancy: A Case Series |
Q57688911 | Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews |
Q26779412 | Use of Insulin Lispro Protamine Suspension in Pregnancy |
Search more.